$2.71T
Total marketcap
$94.61B
Total volume
BTC 49.79%     ETH 17.01%
Dominance

CombiGene AB (publ) COMBI.ST Stock

3.39 SEK {{ price }} -0.586510% {{change_pct}}%
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
67.13M SEK
LOW - HIGH [24H]
3.28 - 3.5 SEK
VOLUME [24H]
9.86K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-1.78 SEK

CombiGene AB (publ) Price Chart

CombiGene AB (publ) COMBI.ST Financial and Trading Overview

CombiGene AB (publ) stock price 3.39 SEK
Previous Close 6.84 SEK
Open 6.85 SEK
Bid 6.85 SEK x 0
Ask 6.96 SEK x 0
Day's Range 6.85 - 6.99 SEK
52 Week Range 6.37 - 10.55 SEK
Volume 3.32K SEK
Avg. Volume 27.71K SEK
Market Cap 135.84M SEK
Beta (5Y Monthly) 1.305747
PE Ratio (TTM) 1.8743169
EPS (TTM) -1.78 SEK
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 2.1 SEK

COMBI.ST Valuation Measures

Enterprise Value 14.93M SEK
Trailing P/E 1.8743169
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 8.1356
Price/Book (mrq) 0.9879033
Enterprise Value/Revenue 0.894
Enterprise Value/EBITDA -0.51

Trading Information

CombiGene AB (publ) Stock Price History

Beta (5Y Monthly) 1.305747
52-Week Change -14.016%
S&P500 52-Week Change 20.43%
52 Week High 10.55 SEK
52 Week Low 6.37 SEK
50-Day Moving Average 6.95 SEK
200-Day Moving Average 8.05 SEK

COMBI.ST Share Statistics

Avg. Volume (3 month) 27.71K SEK
Avg. Daily Volume (10-Days) 18.84K SEK
Shares Outstanding 19.8M
Float 19.64M
Short Ratio N/A
% Held by Insiders 29.34%
% Held by Institutions 1.41%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:20

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -108.34%
Operating Margin (ttm) -177.25%
Gross Margin -84.21%
EBITDA Margin -175.46%

Management Effectiveness

Return on Assets (ttm) -12.095%
Return on Equity (ttm) -12.34%

Income Statement

Revenue (ttm) 16.7M SEK
Revenue Per Share (ttm) 0.84 SEK
Quarterly Revenue Growth (yoy) -84.70%
Gross Profit (ttm) 9.18M SEK
EBITDA -29296260 SEK
Net Income Avi to Common (ttm) -18089932 SEK
Diluted EPS (ttm) 3.66
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 120.51M SEK
Total Cash Per Share (mrq) 6.09 SEK
Total Debt (mrq) 0 SEK
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 21.44
Book Value Per Share (mrq) 6.944

Cash Flow Statement

Operating Cash Flow (ttm) -11881683 SEK
Levered Free Cash Flow (ttm) -3754714 SEK

Profile of CombiGene AB (publ)

Country Sweden
State N/A
City Lidingö
Address Agavagen 52A
ZIP 181 55
Phone 46 7 04 66 31 63
Website https://www.combigene.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 11

CombiGene AB (publ) engages in the development of gene therapy for severe life-altering diseases in Sweden. The company is developing two gene therapy candidates, including CG01, which is in preclinical studies for the treatment of epilepsy and biodistribution and toxicology studies; and CGT2 for the treatment of lipodystrophy. The company has a licensing and collaboration agreement with Danish company Zyneyro to develop a treatment for chronic pain conditions; and with Spark Therapeutics to develop adeno-associated virus (AAV) based gene therapies. CombiGene AB (publ) was founded in 1999 and is headquartered in Lidingö, Sweden.

Q&A For CombiGene AB (publ) Stock

What is a current COMBI.ST stock price?

CombiGene AB (publ) COMBI.ST stock price today per share is 3.39 SEK.

How to purchase CombiGene AB (publ) stock?

You can buy COMBI.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for CombiGene AB (publ)?

The stock symbol or ticker of CombiGene AB (publ) is COMBI.ST.

Which industry does the CombiGene AB (publ) company belong to?

The CombiGene AB (publ) industry is Biotechnology.

How many shares does CombiGene AB (publ) have in circulation?

The max supply of CombiGene AB (publ) shares is 19.8M.

What is CombiGene AB (publ) Price to Earnings Ratio (PE Ratio)?

CombiGene AB (publ) PE Ratio is now.

What was CombiGene AB (publ) earnings per share over the trailing 12 months (TTM)?

CombiGene AB (publ) EPS is -1.78 SEK over the trailing 12 months.

Which sector does the CombiGene AB (publ) company belong to?

The CombiGene AB (publ) sector is Healthcare.

CombiGene AB (publ) COMBI.ST included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
First North Sweden EUR GI FNSEEURGI 1616.78 EUR 1767.36 USD
+0.9
First North Health Care GI FN20GI 939.38 EUR 1026.87 USD
+1.47
First North All-Share EUR FIRSTNORTHEUR 102.34 EUR 111.87 USD
+0.67
First North Sweden SEK PI FNSESEKPI 1878.6 SEK 183.37 USD
+0.16
First North Sweden EUR PI FNSEEURPI 1513.01 EUR 1653.92 USD
+0.67
First North Health Care PI FN20PI 935.08 EUR 1022.17 USD
+1.47
First North All-Share SEK FIRSTNORTHSEK 127.48 SEK 12.44 USD
+0.21
First North All-Share DKK FIRSTNORTHDKK 102.41 DKK 15.01 USD
+0.66
First North Sweden SEK GI FNSESEKGI 2007.48 SEK 195.95 USD
+0.39